Raphael Wisniewski

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Their mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches. Their unique system provides a new solution for multidisciplinary heart teams and their patients by its proven clinical improvements.